Cargando…
Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study
OBJECTIVE: To examine the relative effectiveness of a fourth dose of the Pfizer-BioNTech mRNA (BNT162b2) vaccine compared with three vaccine doses over the span of 10 weeks. DESIGN: Retrospective, test negative, case-control study, with a matched analysis and an unmatched multiple tests analysis. SE...
Autores principales: | Gazit, Sivan, Saciuk, Yaki, Perez, Galit, Peretz, Asaf, Pitzer, Virginia E, Patalon, Tal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127435/ https://www.ncbi.nlm.nih.gov/pubmed/35609888 http://dx.doi.org/10.1136/bmj-2022-071113 |
Ejemplares similares
-
Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine
por: Patalon, Tal, et al.
Publicado: (2022) -
Hybrid immunity against reinfection with SARS-CoV-2 following a previous SARS-CoV-2 infection and single dose of the BNT162b2 vaccine in children and adolescents: a target trial emulation
por: Gazit, Sivan, et al.
Publicado: (2023) -
Mpox Patient Journey in Israel
por: Patalon, Tal, et al.
Publicado: (2023) -
Dynamics of Naturally Acquired Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 in Children and Adolescents
por: Patalon, Tal, et al.
Publicado: (2023) -
An Outbreak of Parvovirus B19 in Israel
por: Patalon, Tal, et al.
Publicado: (2023)